Skip to content

HPV Self-test to Increase Cervical Cancer Screening in Asian Women

Human Papillomavirus (HPV) and Cervical Cancer Intervention to Increase Cervical Cancer Screening for Underserved Asian Women

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04612660
Enrollment
156
Registered
2020-11-03
Start date
2014-09-30
Completion date
2015-07-31
Last updated
2022-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Cancer

Brief summary

The study was to pilot test the feability of using HPV self-sampling testing to increase cervical cancer screening among under-served Asian women through engaging community-based organizations in the greater Philadelphia and New York City area, addressing a significant global cancer burden, the preventable infection-related cervical cancer.

Interventions

BEHAVIORALEducation on cervical cancer prevetnion

Motivational group education by trained bilingual community health educators (CHEs) on cervical cancer prevention

BEHAVIORALDynamic group interaction

Dynamic group interaction and role play discussion sessions on the benefits of Self-Sample collection HPV testing and procedures;

BEHAVIORALPhysician engagement

Engaging community bilingual physicians in cervical cancer screening and referral;

BEHAVIORALPatient Navigation

Patient navigation assistance will be provided to participants who tested HPV positive for further diagnostic testing and treatment.

BEHAVIORALGeneral Health Education

general health education focusing on healthy lifestyle, and prevention of disease through routine health examinations.

Sponsors

Temple University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
30 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

1. gender: female 2. age: 30-55 3. no current diagnosis of cervical cancer, and 4. have not participated in cervical cancer screening within the past 3 years.

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frame
the change in the rate of cervical cancer screeningbaseline, and 6-month follow up

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026